Indonesia seeks to launch home-grown Covid-19 vaccine in third quarter


A healthcare worker inoculates a woman with a dose of the Pfizer vaccine against the Covid-19 during a mass vaccination at a shopping mall in Jakarta. Indonesia has aimed to develop and manufacture its own vaccines domestically since the start of the pandemic. - Reuters

JAKARTA, Feb 20 (Jakarta Post/ANN): Indonesia will seek to launch a home-grown Covid-19 vaccine in August, with the first phase of clinical trials for the Merah Putih vaccine now under way.

Analysts said it was an important development for Indonesia, where more than 65 per cent of the eligible population have been fully vaccinated against Covid-19, if a vaccine can be produced domestically from a trusted source.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Indonesia , Covid-19 , Home Grown , Vaccine , Third Quarter , 2022

   

Next In Aseanplus News

Asean news headlines as at 9pm on Tuesday (April 23)
Jokowi says transition to new government to begin soon
Chinese warships in Cambodia fuel fresh concerns as Wang visits
Thai actor Bright and singer Nene confirm they are dating
Rafizi: Economy continues to strengthen along with Bursa Malaysia
Murder in Spain: Limited edition sneakers worn by suspect match footprints at crime scene
Copter tragedy: 'Dad didn't speak much but he always took care of us'
Indonesia forms task force to tackle child pornography as millions of cases recorded
Copter tragedy: Families still reeling from loss
Copter tragedy: Friends see Lt Cmdr Wan Rezaudeen as a hero

Others Also Read